Li, Qingkai
Liu, Ying
Wang, Yanan
Shan, Xin
Liu, Chunxiao
Li, Zhihua
Cao, Jinglin
Dou, Jian
Xu, Guanjie
Wang, Qiujun
Qie, Xiaojuan
Funding for this research was provided by:
China Primary Health Care Foundation (YLGX-WS-2020014)
Article History
Received: 27 March 2023
Accepted: 12 December 2023
First Online: 19 December 2023
Declarations
:
: The study was designed as a prospective, single-centre, double-blinded, randomized controlled trial that followed the ethical standards stated in the Declaration of Helsinki and the Consolidated Standards of Reporting Trials (CONSORT) reporting guidelines. It was approved by the Medical Ethics Committee of the Third Hospital of Hebei Medical University (Approval No. 2021-003-1) and registered at ClinicalTrials.gov (ChiCTR2100050486; principal investigator: Xiaojuan Qie, M.D.; 28/08/2021). All participants provided written informed consent before enrolment.
: Not applicable.
: The authors declare no competing interests.